The relationship between impulse-control disorders and obsessive-compulsive disorder: A current understanding and future research directions

Psychiatry Research

Volumn 170, Issue 1, 2009, Pages 22-31

  Potenza, Marc Nicholas ^a   Koran, Lorrin Michael ^b   Pallanti, Stefano ^c,d  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^c UNIVERSITY OF FLORENCE   (Italy)

^d MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Addiction; Aggression; Compulsivity; Gambling; Impulse control disorders; Impulsivity; Nomenclature; Obsessive compulsive disorder

Indexed keywords

ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARBAMAZEPINE; ESCITALOPRAM; FLUVOXAMINE; HALOPERIDOL; LITHIUM SALT; NALMEFENE; NALTREXONE; NEUROLEPTIC AGENT; OLANZAPINE; PAROXETINE; PHENYTOIN; PLACEBO; RISPERIDONE; SEROTONIN 1B RECEPTOR; SEROTONIN 1D RECEPTOR; SEROTONIN 2A RECEPTOR; SEROTONIN TRANSPORTER; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; VALPROIC ACID; VENLAFAXINE;

ARTICLE; BEHAVIOR THERAPY; CLINICAL FEATURE; CLINICAL TRIAL; COGNITIVE THERAPY; COMORBIDITY; CULTURAL FACTOR; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DRUG EFFICACY; DRUG RESPONSE; DRUG TOLERABILITY; FAMILY HISTORY; FAMILY THERAPY; GENETIC VARIABILITY; GROUP THERAPY; HEREDITY; HUMAN; IMPULSE CONTROL DISORDER; INTERMITTENT EXPLOSIVE DISORDER; KLEPTOMANIA; MARITAL THERAPY; NEUROBIOLOGY; NONHUMAN; OBSESSIVE COMPULSIVE DISORDER; PATHOLOGICAL GAMBLING; PREVALENCE; PRIORITY JOURNAL; PSYCHOTHERAPY; PYROMANIA; TRICHOTILLOMANIA;

DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; HUMANS; IMPULSE CONTROL DISORDERS; OBSESSIVE-COMPULSIVE DISORDER; SEVERITY OF ILLNESS INDEX;

EID: 70350007154     PISSN: 01651781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psychres.2008.06.036     Document Type: Article

References (168)

1. Aboujaoude E., Koran L.M., Gamel N., Large M.D., and Serpe R.T. potential markers for problematic internet use: a telephone survey of 2513 adults. CNS Spectrums 11 (2006) 750-755
2. Abbott M.W., Volberg R.A., and Ronnberg S. Comparing the New Zealand and Swedish national surveys of gambling and problem gambling. Journal of Gambling Studies 20 (2004) 237-258
3. Alpert J.E., and Spilman M.K. Psychotherapeutic approaches to aggressive and violent patients. Psychiatric Clinics of North America 20 (1997) 453-471
4. American Psychiatric Association Committee on Nomenclature and Statistics. Diagnostic and Statistical Manual of Mental Disorders. 4th Ed. (2000), American Psychiatric Association, Washington, DC Text Revision
5. Anderson S., Bechara A., Damasio H., Tranel D., and Damasio A.R. Impairment of social and moral behavior related to early damage in human prefrontal cortex. Nature Neuroscience 2 (1999) 1032-1037
6. Anholt G.E., Emmelkamp P.M.G., Cath D.C., van Oppen P., Nelissen H., and Smit J.H. Do patients with OCD and pathological gambling have similar dysfunctional cognitions?. Behaviour Research Therapy 42 (2004) 529-537
7. Bechara A. Risky business: emotion, decision-making, and addiction. Journal of Gambling Studies 19 (2003) 23-51
8. Bechara A., Damasio H., Damasio A.R., and Lee G.P. Different contributions of the human amygdala and ventromedial prefrontal cortex to decision-making. Journal of Neuroscience 19 (1999) 5473-5481
9. Bechara A., Damasio H., Tranel D., and Anderson S.W. Dissociation of working memory from decision making within the human prefrontal cortex. Journal of Neuroscience 18 (1998) 428-437
10. Bienvenu O., Samuels J.F., Riddle M.A., Hoehn-Saric R., Liang K.-Y., Cullen B.A.M., Grados M.A., and Nestadt G. The relationship of obsessive-compulsive disorder to possible spectrum disorders: results from a family study. Biological Psychiatry 48 (2000) 287-293
11. Black D.W., Moyer T., and Schlosser S. Quality of life and family history in pathological gambling. Journal of Nervous and Mental Disease 191 (2003) 124-126
12. Blanco C., Petkova E., Ibanez A., and Saiz-Ruiz J. A pilot placebo-controlled study of fluvoxamine for pathological gambling. Annals of Clinical Psychiatry 14 (2002) 9-15
13. Blaszczynski A., Steel Z., and McConaghy N. Impulsivity in pathological gambling: the antisocial impulsivist. Addiction 92 (1997) 75-87
14. Blum K., Cull J.G., Braverman E.R., and Comings D.E. Reward deficiency syndrome. American Scientist 84 (1996) 132-145
15. Brewer, J.A., Potenza, M.N., 2008. The neurobiology and genetics of impulse control disorders: relationships to drug addictions. Biochemical Pharmacology 75, 63-75.
16. Brewer, J.A., Grant, J.E., Potenza, M.N., 2008. The treatment of pathological gambling. Addictive Disorders and Their Treatment 7, 1-13.
17. Buitelaar J.K., Van der Gaag R.J., Cohen-Kettenis P., and Melman C.T. A randomized controlled trial of risperidone in the treatment of aggression in hospitalized adolescents with subaverage cognitive abilities. Journal of Clinical Psychiatry 62 (2001) 239-248
18. Cadoret R.J., Yates W.R., Troughton E., Woddworth G., and Stewart M.A. Genetic-environmental interaction in the genesis of aggressivity and conduct disorders. Archives of General Psychiatry 52 (1995) 916-924
19. Carroll K., Connors G.J., Cooney N.L., DiClemente C.C., Donovan D.M., Kadden R.R., Longabaugh R.L., Rounsaville B.J., Wirtz P.W., and Zweben A. A Cognitive Behavioral Approach: Treating Cocaine Addiction (1998), NIDA, Rockville, MD
20. Cavedini P., Riboldi G., Keller R., D'Annucci A., and Bellodi L. Frontal lobe dysfunction in pathological gambling. Biological Psychiatry 51 (2002) 334-341
21. Cavedini P., Riboldi G., D'Annucci A., Belotti P., Cisima M., and Bellodi L. Decision-making heterogeneity in obsessive-compulsive disorder: ventromedial prefrontal cortex function predicts different treatment outcomes. Neuropsychologia 40 (2002) 205-211
22. Chamberlain S.R., Menzies L., Sahakian B.J., and Fineberg N.A. Lifting the veil on trichotillomania. American Journal of Psychiatry 164 (2007) 568-574
23. Chambers R.A., and Potenza M.N. Neurodevelopment, impulsivity and adolescent gambling. Journal of Gambling Studies 19 (2003) 53-84
24. Chambers, R.A., Bickel, W.K., Potenza, M.N., 2007. A scale-free systems theory of motivation and addiction. Neuroscience and Biobehavioral Reviews 31, 1017-1045.
25. Coccaro E.F., and Kavoussi R.J. Fluoxetine and impulsive aggressive behavior in personality-disordered subjects. Archives of General Psychiatry 54 (1997) 1081-1088
26. Coccaro E.F., and Siever L.J. Pathophysiology and treatment of aggression. In: Charney D., Davis K.L., Coyle J.T., and Nemeroff C. (Eds). Neuropsychopharmacology: The 5th Generation of Progress (2002), Lippincott Williams & Wilkins, Philadelphia, PA 1709-1723
27. Cocarro E.F., Kavoussi R.J., Trestman R.L., Gabriel S.M., Cooper T.B., and Siever L.J. Serotonin function in human subjects: intercorrelations among central 5-HT indices and aggressiveness. Psychiatry Research 73 (1997) 1-14
28. Cocarro E.F., Schmidt C.A., Samuels J.F., and Nestadt G. Lifetime and 1-month prevalence of intermittent explosive disorder in a community sample. Journal of Clinical Psychiatry 65 (2004) 820-824
29. Comings D.E. The molecular genetics of pathological gambling. CNS Spectrums 3 6 (1998) 20-37
30. Comings D.E., Gade-Andavolu R., Gonzalez N., Wu S., Muhleman D., Chen C., Koh P., Farwell K., Blake H., Dietz G., MacMurray J.P., Lesieur H.R., Rugle L.J., and Rosenthal R.J. The additive effect of neurotransmitter genes in pathological gambling. Clinical Genetics 60 (2001) 107-116
31. Crockford D.N., and el-Guebaly N. Psychiatric comorbidity in pathological gambling: a critical review. Canadian Journal of Psychiatry - Revue Canadienne de Psychiatrie 43 (1998) 43-50
32. Cunningham-Williams R.M., and Cottler L.B. The epidemiology of pathological gambling. Seminars in Clinical Neuropsychiatry 6 (2001) 155-166
33. Cunningham-Williams R.M., Cottler L.B., Compton III W.M., and Spitznagel E.L. Taking chances: problem gamblers and mental health disorders - results from the St. Louis Epidemiologic Catchment Area Study. American Journal of Public Health 88 (1998) 1093-1096
34. Curzon G., and Gibson E.L. The serotonergic appetite suppressant fenfluramine. Advances in Experimental Medical Biology 467 (1999) 95-100
35. Damasio, A.R., 1994. Descartes' Error: Emotion, Reason and the Human Brain. New York, NY, Crosset/Putnam.
36. Davanzo P., Yue K., Thomas M.A., Belin T., Mintz J., Venkatraman T.N., Santoro E., Barnett S., and McCracken J. Proton magnetic resonance spectroscopy of bipolar disorder versus intermittent explosive disorder in children and adolescents. American Journal of Psychiatry 160 (2003) 1442-1452
37. Dell'Osso B., Altamura A.C., Allen A., Marazziti D., and Hollander E. Epidemiologic and clinical updates on impulse control disorder: a critical review. European Archives of Psychiatry and Clinical Neuroscience 256 (2006) 464-475
38. Denys D. Pharmacotherapy of obsessive-compulsive disorder and obsessive-compulsive spectrum disorders. Psychiatric Clinics of North America 29 (2006) 553-584
39. Denys D., Burger H., van Megen H., de Geus F., and Westenberg H. A score for predicting response to pharmacotherapy in obsessive-compulsive disorder. International Clinical Psychopharmacology 18 (2003) 315-322
40. Dougherty R.S., Deckersbach T., Marci C., Loh R., Shin L.M., Alpert N.M., Fischman A.J., and Fava M. Ventromedial prefrontal cortex and amygdala dysfunction during an anger induction positron emission tomography study in patients with major depressive disorder with anger attacks. Archives of General Psychiatry 61 (2004) 795-804
41. du Toit P.L., van Kradenburg J., Niehaus D., and Stein D.J. Comparison of obsessive-compulsive disorder in patients with and without putative obsessive compulsive disorder using a structured clinical interview. Comprehensive Psychiatry 45 (2005) 291-300
42. Eisen S.A., Lin N., Lyons M.J., Scherrer J.F., Griffith K., True W.R., Goldberg J., and Tsuang M.T. Familial influences on gambling behavior: an analysis of 3359 twin pairs. Addiction 93 (1998) 1375-1384
43. Ettelt S., Ruhrmann S., Barnow S., Buthz F., Hochrein A., Meyer K., Kraft S., Reck C., Pukrop R., Klosterkotter J., Falkai P., Maier W., Wagner M., Freyberger H.J., and Grabe H.J. Impulsiveness in obsessive-compulsive disorder: results from a family study. Acta Psychiatrica Scandinavica 115 (2007) 41-47
44. Everitt B., and Robbins T.W. Neural systems of reinforcement for drug addiction: from actions to habits to compulsion. Nature Neuroscience 8 (2005) 1481-1489
45. Feder R. Treatment of intermittent explosive disorder with sertraline in 3 patients. Journal of Clinical Psychiatry 60 (1999) 195-196
46. Felthous A.R., Bryant G., Wingerter C.B., and Barratt E. The diagnosis of intermittent explosive disorder in violent men. Bulletin of the American Academy of Psychiatry and the Law 19 (1991) 71-79
47. Findling R.L., McNamara N.K., Branicky L.A., Schluchter M.D., Lemon E., and Blumer J.L. A double-blind pilot study of risperidone in the treatment of conduct disorder. Journal of the American Academy of Child and Adolescent Psychiatry 39 (2001) 509-516
48. Fontenelle L.F., Mendlowicz M.V., and Versiani M. Impulse control disorders in patients with obsessive-compulsive disorder. Psychiatric & Clinical Neuroscience 59 (2005) 30-37
49. Frankle W.G., Lombardo I., New A.S., Goodman M., Talbot P.S., Huang Y., Hwang D.R., Slifstein M., Curry S., Abi-Dargham A., Laruelle M., and Siever L.J. Brain serotonin transporter distribution in subjects with impulsive aggressivity: a positron emission study with [11C]McN 5652. American Journal of Psychiatry 162 (2005) 915-923
50. Frick P.J., Lahey B.B., Loeber R., Stouthamer-Loeber M., Christ M.G., and Hanson K. Familial risk factors to oppositional defiant disorder and conduct disorder: parental psychopathology and maternal parenting. Journal of Consulting and Clinical Psychology 60 (1990) 49-55
51. Gottesman I., and Gould T.D. The endophenotype concept in psychiatry: etymology and strategic intentions. American Journal of Psychiatry 160 (2003) 636-645
52. Grabe H.J., Ruhrmann S., Ettelt S., Buhtz F., Hochrein A., Schulze-Rauschenbach S., Meyer K., Kraft S., Reck C., Pukrop R., Freyberger H.J., Klosterkotter J., Falkai P., John U., Maier W., and Wagner M. Familiality of obsessive-compulsive disorder in nonclinical and clinical subjects. American Journal of Psychiatry 163 (2006) 1986-1992
53. Grant J.E. N-acetyl Cysteine Treatment of Pathological Gambling (2006), International Society for Research on Impulsivity, Paris, France
54. Grant J.E., and Potenza M.N. Impulse control disorders: clinical charactaristics characteristics and pharmacological management. Annals of Clinical Psychiatry 16 (2004) 27-34
55. Grant J.E., and Potenza M.N. In: Grant J.E., and Potenza M.N. (Eds). Impulse Control Disorders A Clinical Text of Men's Mental Health (2006), American Psychiatric Press, Inc., Washington, DC
56. Grant J.E., and Potenza M.N. Escitalopram treatment of pathological gambling with co-occurring anxiety: an open-label pilot study with double-blind discontinuation. International Clinical Psychopharmacology 21 (2006) 203-209
57. Grant J.E., and Potenza M.N. Treatments for pathological gambling and other impulse control disorders. In: Gorman J., and Nathan P. (Eds). A Guide to Treatments That Work (2007), Oxford University Press, Oxford, UK 561-577
58. Grant J.E., Kim S.W., Potenza M.N., Blanco C., Ibanez A., Stevens L.C., and Zaninelli R. Paroxetine treatment of pathological gambling: a multi-center randomized controlled trial. International Clinical Psychopharmacology 18 (2003) 243-249
59. Grant J.E., Levine L., Kim D., and Potenza M.N. Impulse control disorders in adult psychiatric inpatients. American Journal of Psychiatry 162 (2005) 2184-2188
60. Grant J.E., Mancebo M., Pinto A., Eisen J.L., and Rasmussen S.A. Impulse control disorders in adults with obsessive compulsive disorder. Journal of Psychiatry Research 40 (2006) 494-501
61. Grant J.E., Odlaug B.L., and Potenza M.N. Addicted to hairpulling? How an alternate model of trichotillomania may improve treatment outcome. Harvard Review of Psychiatry 15 (2007) 80-85
62. Grant J.E., Potenza M.N., Hollander E., Cunningham-Williams R., Nurminen T., Smits G., and Kallio A. Multicenter investigation of the opioid antagonist nalmefene in the treatment of pathological gambling. American Journal of Psychiatry 163 (2006) 303-312
63. Grant, J.E., Williams, K.A., Potenza, M.N., 2007. Impulse control disorders in adolescent inpatients: Co-occurring disorders and sex differences. Journal of Clinical Psychiatry 68, 1584-1592.
64. Gross-Isseroff R., Cohen R., Sasson Y., Voet H., and Zohar J. Serotonergic dissection of obsessive compulsive symptoms: a challenge study with m-chlorophenylpiperazine and sumatripta. Neuropsychobiology 50 (2004) 200-205
65. Halperin J.M., Schulz K.P., McKay K.E., Sharma V., and Newcorn J.H. Familial correlates of central serotonin function in children with disruptive behavior disorders. Psychiatry Research 119 (2003) 205-216
66. Hemmings S.M.J., and Stein D.J. The current status of association studies in obsessive-compulsive disorder. Psychiatric Clinics of North America 29 (2006) 411-444
67. Hodgins D.C., Currie S.R., and el-Guebaly N. Motivational enhancement and self-help treatments for problem gambling. Journal of Clinical and Consulting Psychology 69 (2001) 50-57
68. Hohagen F., Winkelmann G., Rasche-Ruchle H., Hand I., Konig A., Munchau N., Hiss H., Geiger-Kabisch C., Kappler C., Schramm P., Rey E., Aldenhoff J., and Berger M. Combination of behaviour therapy with fluvoxamine in comparison with behaviour therapy and placebo. Results of a multicentre study. British Journal of Psychiatry. Supplement 35 (1998) 71-78
69. Holden C. 'Behavioral' addictions: do they exist?. Science 294 (2001) 980-982
70. Hollander E., and Wong C.M. Obsessive-compulsive spectrum disorders. Journal of Clinical Psychiatry 56s4 (1995) 3-6
71. Hollander E., DeCaria C., Gully R., Nitescu A., Suckow R.F., Gorman J.M., Klein D.F., and Liebowitz M.R. Effects of chronic fluoxetine treatment on behavioral and neuroendocrine responses to meta-chlorophenylpiperazine in obsessive-compulsive disorder. Psychiatry Research 36 (1991) 1-17
72. Hollander E., DeCaria C.M., Finkell J.N., Begaz T., Wong C.M., and Cartwright C. A randomized double-blind fluvoxamine/placebo crossover trial in pathological gambling. Biological Psychiatry 47 (2000) 813-817
73. Hollander E., Kaplan A., and Pallanti S. Pharmacological treatments. In: Grant J.E., and Potenza M.N. (Eds). Pathological gambling: a clinical guide to treatment (2004), American Psychiatric Press, Inc, Washington, DC 189-206
74. Hollander E., Pallanti S., Allen A., Sood E., and Baldini Rossi N. Does sustained-release lithium reduce impulsive gambling and affective instability versus placebo in pathological gamblers with bipolar spectrum disorders?. American Journal of Psychiatry 162 (2005) 137-145
75. Hollander E., Stein D.J., Kwon J.H., Rowland C., Wong C.M., Broatch J., and Himelin C. Psychosocial function and economic costs of obsessive-compulsive disorder. CNS Spectrums 2 10 (1997) 16-25
76. Ibanez A., Blanco C., de Castro I.P., Fernandez-Piqueras J., and Saiz-Ruiz J. Genetics of pathological gambling. Journal of Gambling Studies 19 (2003) 11-22
77. Insel T.R., and Pickar D. Naloxone administration in obsessive-compulsive disorder: report of two cases. American Journal of Psychiatry 140 (1983) 1219-1220
78. Jentsch J., and Taylor J.R. Impulsivity resulting from frontostriatal dysfunction in drug abuse: implications for the control of behavior by reward-related stimuli. Psychopharmacology 146 (1999) 373-390
79. Karno M., Golding J.M., Sorenson S.B., and Burnam M.A. The epidemiology of obsessive-compulsive disorder in five US communities. Archives of General Psychiatry 45 (1988) 1094-1099
80. Kendler K.S., Prescott C., Myers J., and Neale M.C. The structure of genetic and environmental risk factors for common psychiatric and substance use disorders in men and women. Archives of General Psychiatry 60 (2003) 929-937
81. Kessler R.C., Coccaro E.F., Fava M., Jaeger S., Jin R., and Walters E. The prevalence and correlates of DSM-IV intermittent explosive disorder in the national comorbidity survey replication. Archives of General Psychiatry 63 (2006) 669-678
82. Keuler D.J., Altemus M., Michelson D., Greenberg B., and Murphy D.L. Behavioral effects of naloxone infusion in obsessive-compulsive disorder. Biological Psychiatry 40 (1996) 154-156
83. Kim S.W., Grant J.E., Adson D.E., and Shin Y.C. Double-blind naltrexone and placebo comparison study in the treatment of pathological gambling. Biological Psychiatry 49 (2000) 914-921
84. Kim S.W., Grant J.E., Adson D.E., Shin Y.C., and Zaninelli R. A double-blind, placebo-controlled study of the efficacy and safety of paroxetine in the treatment of pathological gambling disorder. Journal of Clinical Psychiatry 63 (2002) 501-507
85. Knutson B., Fong G.W., Adams C.M., Varner J.L., and Hommer D. Dissociation of reward anticipation and outcome with event-related fMRI. NeuroReport 12 (2001) 3683-3687
86. Koran L.M., Faber R.J., Aboujaoude E., Large M.D., and Serpe R.T. Estimated prevalence of compulsive buying in the United States. American Journal of Psychiatry 163 (2006) 1806-1812
87. Korff S., and Harvey B.H. Animal models of obsessive-compulsive disorder: rational to understanding psychobiology and pharmacology. Psychiatric Clinics of North America 29 (2006) 371-390
88. Kreek M.J., Nielsen D.A., Butelman E.R., and LaForge K.S. Genetic influences on impulsivity, risk-taking, stress responsivity and vulnerability to drug abuse and addiction. Nature Neuroscience 8 (2005) 1450-1457
89. Krueger R.F. The structure of common mental disorders. Archives of General Psychiatry 56 (1999) 921-926
90. Lappalainen J., Long J.C., Eggert M., Ozaki N., Robin R.W., Brown G.L., Naukkarinen H., Virkkunen M., Linnoila M., and Goldman D. Linkage of antisocial alcoholism to the serotonin 5-HT1B receptor gene in 2 populations. Archives of General Psychiatry 55 (1998) 989-994
91. Leckman J.F., Grice D.E., Barr L.C., de Vries A.L., Martin C., Cohen D.J., McDougle C.J., Goodman W.K., and Rasmussen S.A. Tic-related versus non-tic-related obsessive compulsive disorder. Anxiety 1 (1994) 208-215
92. Leckman J.F., Pauls D.L., Zhang H., Rosario-Campos M.C., Katsovich L., Kidd K.K., Pakstis A.J., Alsobrook J.P., Robertson M.M., McMahon W.M., Walkup J.T., van de Wetering B.J., King R.A., Cohen D.J., and Tourette Syndrome Association International Consortium for Genetics. Obsessive-compulsive symptom dimensions in affected sibling pairs with Gilles de Tourette syndrome. American Journal of Medical Genetics 116B (2003) 60-68
93. Leckman J.F., Zhang H., Alsobrook J.P., and Pauls D.L. Symptom dimension in obsessive-compulsive disorder: toward quantitative phenotypes. American Journal of Medical Genetics (Neuropsychiatric Genetics) 105 (2001) 28-30
94. Ledgerwood D.M., Steinberg M.A., Wu R., and Potenza M.N. Self-reported gambling-related suicidality among gambling helpline callers. Psychology of Addictive Behaviors 19 (2005) 175-183
95. Lejoyeaux M., Ades J., Tassain V., and Solomon J. Phenomenology and psychopathology of uncontrolled buying. American Journal of Psychiatry 153 (1996) 1524-1529
96. Lenane M.C., Swedo S.E., Rapoport J.L., Leonard H., Sceery W., and Guroff J.J. Rates of obsessive compulsive disorder in first degree relatives of patients with trichotillomania: a research note. Journal of Child Psychology and Psychiatry 33 (1992) 925-933
97. Li C.-S.R., and Chen S.-H. Obsessive-compulsiveness and impulsivity in a non-clinical population of adolescent males and females. Psychiatry Research 149 (2007) 129-138
98. Liu, T., Potenza, M.N., 2007. Problematic internet use: clinical implications. CNS Spectrums 12, 453-466.
99. Lochner C., and Stein D.J. Does work on obsessive-compulsive spectrum disorders contribute to the understanding of the heterogeneity of obsessive-compulsive disorder?. Progress in Neuro-Psychopharmacology & Biological Psychiatry 30 (2006) 353-361
100. Lochner C., Hemmings S.M.J., Kinnear C.J., Niehaus D.J., Nel D.G., Corfield V.A., Moolman-Smook J.C., Seedat S., and Stein D.J. Cluster analysis of obsessive-compulsive spectrum disorder in patients with obsessive-compulsive disorder: clinical and genetic correlates. Comprehensive Psychiatry 46 (2005) 14-19
101. Mannelli P., Patkar A.A., Peindl K., Tharwani H., Gopalakrishnan R., Hill K.P., and Berrettini W.H. Polymorphism in the serotonin transporter gene and moderators of prolactin response to meta-chlorophenylpiperazine in African-American cocaine abusers and controls. Psychiatry Research 144 (2006) 99-108
102. Mataix-Cols D., and van den Heuvel O.A. Common and distinct neural correlates of obsessive-compulsive disorder and related disorders. Psychiatric Clinics of North America 29 (2006) 391-410
103. Mataix-Cols D., Wooderson S., Lawrence N., Brammer M.J., Speckens A., and Phillips M.L. Distinct neural correlates of washing, checking, and hoarding symptom dimensions in obsessive-compulsive disorder. Archives of General Psychiatry 61 (2004) 564-576
104. Matsunaga H., Kiriike N., Matsui T., Oya K., Okino K., and Stein D.J. Impulsive disorders in Japanese adult patients with obsessive-compulsive disorder. Comprehensive Psychiatry 46 (2005) 105-110
105. McClure S., Laibson D.I., Loewenstein G., and Cohen J.D. Separate neural systems value immediate and delayed monetary rewards. Science 306 (2004) 503-507
106. McDougle C.J., Goodman W.K., Leckman J.F., Lee N.C., Heninger G.R., and Price L.H. Haloperidol addition in fluvoxamine-refractory obsessive compulsive disorder: a double-blind, placebo-controlled study in patients with and without tics. Archives of General Psychiatry 51 (1994) 302-308
107. McDougle C.J., Price L.H., Goodman W.K., Charney D.S., and Heninger G.R. A controlled trial of lithium augmentation in fluvoxamine-refractory obsessive compulsive disorder: lack of efficacy. Journal of Clinical Psychopharmacology 11 (1991) 175-184
108. McElroy S.L., Keck P.E., Pope Jr. H.G., Smith J.M.R., and Stratkowski S.M. Compulsive buying: a report of 20 cases. Journal of Clinical Psychiatry 55 (1994) 242-248
109. McElroy S.L., Soutullo C.A., Beckman D.A., Taylor Jr. P., and Keck Jr. P.E. DSM-IV intermittent explosive disorder: a report of 27 cases. Journal of Clinical Psychiatry 69 (1998) 203-210
110. Miller, W.R., 1995. Motivational enhancement therapy with drug abusers. Retrieved January 15, 2005, from http://motivationalinterview.org/clinical/METDrugAbuse.PDF.
111. Mohammadi M.R., Ghanizadeh A., Rahgozar M., Noorbala A.A., Davidian H., Afzali H.M., Naghavi H.R., Yazdi S.A., Saberi S.M., Mesgarpour B., Akhondzadeh S., Alaghebandrad J., and Tehranidoost M. Prevalence of obsessive-compulsive disorder in Iran. BMC Psychiatry 4 (2004) 2
112. Monopolis S., and Lion J.R. Problems in the diagnosis of intermittent explosive disorder. American Journal of Psychiatry 140 (1983) 1200-1202
113. Monteleone P., Catapano F., Bortolotti F., and Maj M. Plasma prolactin response to d-fenfluramine in obsessive-compulsive patients before and after fluvoxamine treatment. Biological Psychiatry 42 (1997) 175-180
114. Muthen B. Should substance use disorders be considered as categorical or dimensional?. Addiction 101 s1 (2006) s6-s16
115. New A.S., Buchsbaum M., Hazlett E.A., Goodman M., Koenigsberg H.W., Lo J., Iskander L., Newmark R., Brand J., O'Flynn K., and Siever L.J. Fluoxetine increases relative metabolic rate in prefrontal cortex in impulsive aggression. Psychopharmacology 176 (2004) 451-458
116. New A.S., Hazlett E.A., Buchsbaum M.S., Goodman M., Reynolds D., Mitropoulou V., Sprung L., Shaw Jr. R.B., Koenigsberg H., Platholi J., Silverman J., and Siever L.J. Blunted prefrontal cortical 18-fluorodeoxyglucose positron emission tomography response to meta-chlorophenylpiperazine in impulsive aggression. Archives of General Psychiatry 59 (2002) 621-629
117. New A.S., Trestman R.F., Mitropoulou V., Goodman M., Koenigsberg H.H., Silverman J., and Siever L.J. Low prolactin response to fenfluramine in impulsive aggression. Journal of Psychiatric Research 38 (2004) 223-230
118. Neziroglu F., Henricksen J., and Yaryura-Tobias J.A. Psychotherapy of obsessive-compulsive disorder and spectrum: established facts and advances, 1995- 2005. Psychiatric Clinics of North America 29 (2006) 585-604
119. Olivier B., and Young L.J. Animal models of aggression. In: Charney D., Davis K.L., Coyle J.T., and Nemeroff C. (Eds). Neuropsychopharamcology: The 5th Generation of Progress (2002), Lippincott Williams & Wilkins, Philadelphia, PA 1699-1708
120. Olvera R.L. Intermittent explosive disorder: epidemiology, diagnosis and management. CNS Drugs 16 (2002) 517-526
121. Patkar A.A., Mannelli P., Hill K.P., Peindl K., Pae C.U., and Lee T.H. Relationship of prolactin response to meta-chlorophenylpiperazine with severity of drug use in cocaine dependence. Human Psychopharmacology 21 (2006) 367-375
122. Pauls D.L., Mundo E., and Kennedy J.L. The pathophysiology and genetics of obsessive-compulsive disorder. In: Nemeroff C., Coyle J., Charney D., and Davis K. (Eds). Neuropsychopharmacology: the 5th Generation of Progress (2002), Lippincott Williams and Wilkins, Baltimore, MD 1609-1619
123. Perez de Castro I., Ibanez A., Saiz-Ruiz J., and Fernandez-Piqueras J. Genetic contribution to pathological gambling: possible association between a DNA polymorphism at the serotonin transporter gene (5HTT) and affected men. Pharmacogenetics 9 (1999) 397-400
124. Perez de Castro I., Ibanez A., Torres P., Saiz-Ruiz J., and Fernandez-Piqueras J. Genetic association study between pathological gambling and a functional DNA polymorphism at the D4 receptor gene. Pharmacogenetics 7 (1997) 345-348
125. Petry N.M. Pathological gamblers, with and without substance use disorders, discount delayed rewards at high rates. Journal of Abnormal Psychology 110 (2001) 482-487
126. Petry N.M. Gambling participation and problems among Southeast Asian refugees. Psychiatric Services 54 (2003) 1142-1148
127. Petry N.M. Gamblers anonymous and cognitive-behavioral therapies for pathological gamblers. Journal of Gambling Studies 21 (2005) 27-33
128. Petry N.M. Should the scope of addictive behaviors be broadened to include pathological gambling?. Addiction 101 s1 (2006) 152-160
129. Petry N.M., and Casarella T. Excessive discounting of delayed rewards in substance abusers with gambling problems. Drug and Alcohol Dependence 56 (1999) 25-32
130. Petry N.M., Alessi S.M., Carroll K.M., Hanson T., MacKinnon S., Rounsaville B., and Sierra S. Cognitive-behavioral therapy for pathological gamblers. Journal of Consulting and Clinical Psychology 74 (2006) 555-567
131. Petry N.M., Stinson F.S., and Grant B.F. Co-morbidity of DSM-IV pathological gambling and other psychiatric disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Journal of Clinical Psychiatry 66 (2005) 564-574
132. Ponce G., Jiminez-Ariero M.A., Rubio G., Hoenicka J., Ampuero I., Ramos J.A., and Palomo T. The A1 allele of the DRD 2 gene (Taq1 A polymorphism) is associated with antisocial personality in a sample of alcohol-dependent patients. European Psychiatry 18 (2003) 356-360
133. Potenza M.N. The neurobiology of pathological gambling. Seminars in Clinical Neuropsychiatry 6 (2001) 217-226
134. Potenza M.N. Should addictive disorders include non-substance-related conditions?. Addiction 101 s1 (2006) 142-151
135. Potenza M.N. Impulse control disorders and co-occurring disorders: dual diagnosis considerations. Journal of Dual Diagnosis 3 (2007) 47-57
136. Potenza, M.N., 2007. Impulsivity and Compulsivity in Pathological Gambling and Obsessive-Compulsive Disorder. Revista Brasileira de Psiquiatria 29, 105-106.
137. Potenza M.N., and Hollander E. Pathological gambling and impulse control disorders. In: Charney D., Davis K.L., Coyle J.T., and Nemeroff C. (Eds). Neuropsychopharmacology: the 5th Generation of Progress (2002), Lippincott Williams and Wilkins, Baltimore, MD
138. Potenza M.N., Kosten T.R., and Rounsaville B.J. Pathological gambling. JAMA 286 (2001) 141-144
139. Potenza M.N., Leung H.-C., Blumberg H.P., Peterson B.S., Fulbright R.K., Lacadie C.M., Skudlarski P., and Gore J.C. An fMRI stroop study of ventromedial prefrontal cortical function in pathological gamblers. American Journal of Psychiatry 160 (2003) 1990-1994
140. Potenza M.N., Steinberg M.A., McLaughlin S.D., Wu R., Rounsaville B.J., and O'Malley S.S. Gender-related differences in the charactaristics characteristics of problem gamblers using a gambling helpline. American Journal of Psychiatry 158 (2001) 1500-1505
141. Potenza M.N., Steinberg M.A., Skudlarski P., Fulbright R.K., Lacadie C.M., Wilber M.K., Rounsaville B.J., Gore J.C., and Wexler B.E. Gambling urges in pathological gamblers: an fMRI study. Archives of General Psychiatry 60 (2003) 828-836
142. Potenza M.N., Xian H., Shah K., Scherrer J.F., and Eisen S.A. Shared genetic contributions to pathological gambling and major depression in men. Archives of General Psychiatry 62 (2005) 1015-1021
143. Rasmussen S.A., and Eisen J.L. The epidemiology and clinical features of obsessive compulsive disorder. Psychiatric Clinics of North America 15 (1992) 743-758
144. Rauch S.L., Dougherty D.D., Shin L.M., Alpert N.M., Manzo P., Leahy L., Fischman A.J., Jenike M.A., and Baer L. Neural correlates of factor-analyzed OCD symptom dimensions: a PET Study. CNS Spectrums 3 7 (1998) 37-43
145. Reist C., Nakamura K., Sagart E., Sokolski K.N., and Fujimoto K.A. Impulsive aggressive behavior: open-label treatment with escitalopram. Journal of Clinical Psychiatry 64 (2003) 81-85
146. Reuter J., Raedler T., Rose M., Hand I., Glascher J., and Buchel C. Pathological gambling is linked to reduced activation of the mesolimbic reward system. Nature Neuroscience 8 (2005) 147-148
147. Robins, L., Regier, D.A., 1991. Psychiatric disorders in America. New York, Free Press, Macmillan.
148. Rodriguez-Jimenez R., Avila C., Ponce G., Ibanez M.I., Rubio G., Jimenez-Arriero M.A., Ampuero I., Ramos J.A., Hoenicka J., and Palomo T. The Taq1A polymorphism linked to the DRD2 gene is related to lower attention and less inhibitory control in alcoholic patients. European Psychiatry 21 (2006) 66-69
149. Rosario-Campos M.C., Leckman J.F., Curi M., Quatrano S., Katsovitch L., Miguel E.C., and Pauls D.L. A family study of early-onset obsessive-compulsive disorder. American Journal of Medical Genetics Part B 136B (2005) 92-97
150. Saudou F., Amara D.A., Dierich A., LeMeur M., Ramboz S., Segu L., Buhot M.C., and Hen R. Enhanced aggressive behavior in mice lacking 5-HT1B receptor. Science 265 (1994) 1875-1878
151. Saxena S., Brody A.L., Maidment K.M., Smith E.C., Zohrabi N., Katz E., Baker S.K., and Baxter Jr. L.R. Cerebral glucose metabolism in obsessive-compulsive hoarding. American Journal of Psychiatry 162 (2005) 1038-1048
152. Schultz W., Tremblay L., and Hollerman J.R. Reward processing in primate orbitofrontal cortex and basal ganglia. Cerebral Cortex 10 (2000) 272-284
153. Shaffer H.J., Hall M.N., and Vander Bilt J. Estimating the prevalence of disordered gambling in the United States and Canada: a research synthesis. American Journal of Public Health 89 (1999) 1369-1376
154. Shah K.R., Eisen S.A., Xian H., and Potenza M.N. Genetic studies of pathological gambling: a review of methodology and analyses of data from the Vietnam Era Twin (VET) Registry. Journal of Gambling Studies 21 (2005) 177-201
155. Shah K.R., Potenza M.N., and Eisen S.A. Biological basis for pathological gambling. In: Grant J.E., and Potenza M.N. (Eds). Pathological Gambling: A Clinical Guide to Treatment (2004), American Psychiatric Press, Inc., Washington, DC 127-144
156. Siever L.J., Buchsbaum M.S., New A.S., Spiegel-Cohen J., Wei T., Hazlett E.A., Sevin E., Nunn M., and Mitropoulou V. d,l-fenfluaramine response in impulsive personality disorder assessed with [18F]fluorodexyglucose positron emission tomography. Neuropsychopharmacology 20 (1999) 413-423
157. Slutske W.S., Caspi A., Moffitt T.E., and Poulton R. Personality and problem gambling: a prospective study of a birth cohort of young adults. Archives of General Psychiatry 62 (2005) 769-775
158. Slutske W.S., Eisen S., True W.R., Lyons M.J., Goldberg J., and Tsuang M. Common genetic vulnerability for pathological gambling and alcohol dependence in men. Archives of General Psychiatry 57 (2000) 666-674
159. Slutske W.S., Eisen S., Xian H., True W.R., Lyons M.J., Goldberg J., and Tsuang M. A twin study of the association between pathological gambling and antisocial personality disorder. Journal of Abnormal Psychology 110 (2001) 297-308
160. Snider L.A., and Swedo S.E. PANDAS: current status and directions for research. Molecular Psychiatry 9 (2004) 900-907
161. Stein D.J., and Lochner C. Obsessive-compulsive spectrum disorders: a multidimensional approach. Psychiatric Clinics of North America 29 (2006) 343-351
162. Sylvain C., Ladouceur R., and Boisvert J.M. Cognitive and behavioral treatment of pathological gambling: a controlled study. Journal of Consulting and Clinical Psychology 65 (1997) 727-732
163. Tamminga C.A., and Nestler E.J. Pathological gambling: focusing on the addiction, not the activity. American Journal of Psychiatry 163 (2006) 180-181
164. Tavares H., Zilberman M.L., Beites F.J., and Gentil V. Gender differences in gambling progression. Journal of Gambling Studies 17 (2001) 151-160
165. Tiefenbacher S., Davenport M.D., Novak M.A., Pouliot A.L., and Meyer J.S. Fenfluramine challenge, self-injurious behavior, and aggression in rhesus monkeys. Physiological Behavior 80 (2003) 327-331
166. Torres A.R., Prince M.J., Bebbington P.E., Bhugra D., Brugha T.S., Farrell M., Jenkins R., Lewis G., Meltzer H., and Singleton N. Obsessive-compulsive disorder: prevalence, comorbidity, impact, and help-seeking in the British National Psychiatric Morbidity Survey of 2000. American Journal of Psychiatry 163 (2006) 1978-1985
167. Williams, W.A., Potenza, M.N., 2008. The neurobiology of impulse control disorders. Revista Brasiliera Psiquiatria 30 (Suppl 1), S24-S30.
168. World Health Organization, 2003. International Statistical Classification of Diseases and Related Health Problems, 10th Revision. http://www.who.int/classifications/icd/en/. Accessed February 5, 2006.